The Relative Strength (RS) Rating for Albemarle jumped into a new percentile Thursday, with a rise from 70 to 82.
Looking For The Best Stocks To Buy And Watch? Start Here
IBD's unique RS Rating identifies market leadership by showing how a stock's price action over the last 52 weeks measures up against that of other stocks on the major indexes.
Decades of market research shows that the best stocks typically have an RS Rating of at least 80 in the early stages of their moves.
While Albemarle is not near an ideal buying range right now, see if it manages to form and break out from a proper chart pattern.
Top and bottom line growth moved higher last quarter. Earnings were up 175%, compared to 0% in the prior report. Revenue increased from -21% to -7%.
Albemarle holds the No. 12 rank among its peers in the Chemicals-Specialty industry group. Perimeter Solutions, Solaris Energy Infr and NewMarket are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
